Skip to main content
Fig. 5 | Gut Pathogens

Fig. 5

From: Impact of invasive infections on clinical outcomes in acute pancreatitis: early predictive factors and implications for prophylactic anti-infective therapy

Fig. 5

Heatmap of detected pathogens and corresponding acquired antibiotic or antifungal drug resistances. Colored boxes depict frequency distribution of acquired drug resistances of the detected pathogens from 0% in blue to 100% in red. Intrinsic resistances of the detected pathogens pursuant to the EUCAST (The European Committee on Antimicrobial Susceptibility Testing; http://www.eucast.org) documents are depicted as black boxes. a pathogens detected from local body fluids or (peri-) pancreatic necroses. b pathogens detected systemically from blood cultures. Carbap Carbapenem; Gyrase Gyrase inhibitor; 1st C., 2nd, 3rd Cephalosp, 4th 1st, 2nd, 3rd, 4th generation cephalosporin; Aminogl. Aminoglycosides; M Makrolide; Glykop. Glycopeptides; Pol Polyenes; Echino. Echinocandins; Sulfameth. Sulfamethoxazole; † Typical pathogens of the gut microbioma

Back to article page

Gut Pathogens

ISSN: 1757-4749